GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cheng Du Sheng Nuo Biotec Co Ltd (SHSE:688117) » Definitions » Net Cash per Share

Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Net Cash per Share : ¥-3.37 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cheng Du Sheng Nuo Biotec Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Cheng Du Sheng Nuo Biotec Co's Net Cash per Share for the quarter that ended in Sep. 2024 was ¥-3.37.

The historical rank and industry rank for Cheng Du Sheng Nuo Biotec Co's Net Cash per Share or its related term are showing as below:

During the past 7 years, the highest Price-to-Net-Cash Ratio of Cheng Du Sheng Nuo Biotec Co was 49.13. The lowest was 11.57. And the median was 15.66.

SHSE:688117's Price-to-Net-Cash is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.92
* Ranked among companies with meaningful Price-to-Net-Cash only.

Cheng Du Sheng Nuo Biotec Co Net Cash per Share Historical Data

The historical data trend for Cheng Du Sheng Nuo Biotec Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cheng Du Sheng Nuo Biotec Co Net Cash per Share Chart

Cheng Du Sheng Nuo Biotec Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial -1.70 -0.31 2.14 0.81 -1.49

Cheng Du Sheng Nuo Biotec Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.44 -1.49 -1.77 -2.80 -3.37

Competitive Comparison of Cheng Du Sheng Nuo Biotec Co's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cheng Du Sheng Nuo Biotec Co's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's Price-to-Net-Cash falls into.


;
;

Cheng Du Sheng Nuo Biotec Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Cheng Du Sheng Nuo Biotec Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(269.129-435.629-0.167)/112.000
=-1.49

Cheng Du Sheng Nuo Biotec Co's Net Cash per Share for the quarter that ended in Sep. 2024 is calculated as

Net Cash per Share (Q: Sep. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(230.615-609.403-0.037)/112.419
=-3.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cheng Du Sheng Nuo Biotec Co  (SHSE:688117) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Cheng Du Sheng Nuo Biotec Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Cheng Du Sheng Nuo Biotec Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cheng Du Sheng Nuo Biotec Co Business Description

Traded in Other Exchanges
N/A
Address
Section 1, Gongye Avenue, Jinyuan Town, Dayi County, Sichuan Province, Chengdu, CHN, 611330
Cheng Du Sheng Nuo Biotec Co Ltd is a independent research and development, production and sales of peptide raw materials and preparation products.
Executives
Wang Xiao Li Directors, senior managers
Lu Chang Liang senior management
Dong Hua Jian Core technical personnel
Wen Yong Jun Directors, senior managers, core technical personnel
Wu Li Directors, senior managers
Guo De Wen Core technical personnel
Yu Xiao Hai Directors, senior managers
Ma Zhong Gang Senior management, core technical personnel
Zhang Hong Yan Directors, senior managers

Cheng Du Sheng Nuo Biotec Co Headlines

No Headlines